<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>1476-5926-2-S1-S6</ui>
   <ji>1476-5926</ji>
   <fm>
      <dochead>Proceedings</dochead>
      <bibl>
         <title>
            <p>Thioredoxin prevents thioacetamide-induced acute hepatitis</p>
         </title>
         <aug>
            <au id="A1" ca="yes">
               <snm>Okuyama</snm>
               <fnm>Hiroaki</fnm>
               <insr iid="I1"/>
               <email>hokuyama@yf7.so-net.ne.jp</email>
            </au>
            <au id="A2">
               <snm>Shimahara</snm>
               <fnm>Yasuyuki</fnm>
               <insr iid="I1"/>
               <email>shima-kyt@umin.u-tokyo.ac.jp</email>
            </au>
            <au id="A3">
               <snm>Nakamura</snm>
               <fnm>Hajime</fnm>
               <insr iid="I2"/>
               <email>hnakamur@kuhp.kyoto-u.ac.jp</email>
            </au>
            <au id="A4">
               <snm>Araya</snm>
               <fnm>Shinichi</fnm>
               <insr iid="I2"/>
               <email>saraya@virus.kyoto-u.ac.jp</email>
            </au>
            <au id="A5">
               <snm>Kawada</snm>
               <fnm>Norifumi</fnm>
               <insr iid="I3"/>
               <email>kawadanori@med.osaka-cu.ac.jp</email>
            </au>
            <au id="A6">
               <snm>Yamaoka</snm>
               <fnm>Yoshio</fnm>
               <insr iid="I3"/>
               <email>yy@kuhp.kyoto-u.ac.jp</email>
            </au>
            <au id="A7">
               <snm>Yodoi</snm>
               <fnm>Junji</fnm>
               <insr iid="I2"/>
               <email>yodoi@virus1.virus.kyoto-u.ac.jp</email>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Department of Gastroenterological Surgery, Graduate School of Medicine, Kyoto University, Japan</p>
            </ins>
            <ins id="I2">
               <p>Department of Biological Responses, Laboratory of Infection and Prevention, Institute for Virus Research, Kyoto University; Shogoin, Kawahara-cho, Sakyo-ku, Kyoto, Japan 606-8397</p>
            </ins>
            <ins id="I3">
               <p>Department of Hepatology, Graduate School of Medicine, Osaka City University, Japan</p>
            </ins>
         </insg>
         <source>Comparative Hepatology</source>
         <supplement>
            <title>
               <p>11th International Symposium on the Cells of the Hepatic Sinusoid and their Relation to Other Cells</p>
            </title>
         </supplement>
         <conference>
            <title>
               <p>11th International Symposium on the Cells of the Hepatic Sinusoid and their Relation to Other Cells</p>
            </title>
            <location>Tucson, Arizona, USA</location>
            <date-range>25&#8211;29 August, 2002</date-range>
         </conference>
         <issn>1476-5926</issn>
         <pubdate>2004</pubdate>
         <volume>3</volume>
         <issue>Suppl 1</issue>
         <fpage>S6</fpage>
         <url>http://www.comparative-hepatology.com/content/3/S1/S6</url>
         <xrefbib>
            <pubidlist>
               <pubid idtype="doi">10.1186/1476-5926-2-S1-S6</pubid>
               <pubid idtype="pmpid">14960158</pubid>
            </pubidlist>
         </xrefbib>
      </bibl>
      <history>
         <pub>
            <date>
               <day>14</day>
               <month>1</month>
               <year>2004</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2004</year>
         <collab>Okuyama et al; licensee BioMed Central Ltd</collab>
         <note>This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</note>
      </cpyrt>
   </fm>
   <bdy>
      <sec>
         <st>
            <p>Introduction</p>
         </st>
         <p>Thioredoxin (Trx) is an endogenous multifunctional protein with a redox-active disulfide/dithiol within the conserved active site sequence: -Cys-Gly-Pro-Cys- <abbrgrp><abbr bid="B1">1</abbr></abbrgrp>. Trx is also a stress-inducible protein whose expression is enhanced by various types of stresses, e.g., viral infection, exposure to UV light, x-ray irradiation, and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) <abbrgrp><abbr bid="B2">2</abbr></abbrgrp>. Furthermore, Trx is a scavenger of reactive oxygen species (ROS), and recombinant Trx has protective activity against ROS-mediated cytotoxicity <abbrgrp><abbr bid="B3">3</abbr></abbrgrp>. We have previously reported that Trx attenuates an ischemic brain damage by scavenging radicals <abbrgrp><abbr bid="B4">4</abbr></abbrgrp>.</p>
         <p>Based on these considerations, we hypothesized that Trx could attenuate oxidants-mediated acute hepatitis. TAA is known to be a hepatotoxin via generation of free radicals, resulting in ROS-mediated acute hepatitis. In the present study, we subjected wild type (Wt) mice and Trx transgenic (Tg) mice to TAA-induced acute lethal hepatitis. Our findings shed light on the protective role of Trx for acute liver injury.</p>
      </sec>
      <sec>
         <st>
            <p>Methods</p>
         </st>
         <sec>
            <st>
               <p>TAA-induced Acute Lethal Hepatitis</p>
            </st>
            <p>Male mice weighing 25&#8211;30 g were used for <it>in vivo </it>liver injury models. We injected TAA (100 &#8211;g/g) into Trx Tg mice (n = 16) and Wt mice (n = 16). We observed the survival rate of TAA-treated mice until 7 days. Moreover, to estimate the pathophysiological values of livers from Wt (n = 9) and Tg mice (n = 9), twenty-four hours after TAA administration, mice were anesthetized by diethylether, and the livers were removed.</p>
         </sec>
      </sec>
      <sec>
         <st>
            <p>Results</p>
         </st>
         <sec>
            <st>
               <p>Prevention of acute lethal hepatitis in Tg mice</p>
            </st>
            <p>We used Tg mice to check the protective role of Trx for acute hepatitis. We subjected both Wt and Tg mice to TAA-induced acute lethal hepatitis. Survival rate after TAA administration was significantly higher in Tg mice (n = 16) than in Wt mice (n = 16) (P &amp;lt; 0.01). Twenty four hours after TAA administration, the AST and ALT levels were significantly lower in Tg mice than in Wt mice (AST; 7,930 U/ml in Wt mice vs 1,417 U/ml in Tg mice, P &amp;lt; 0.01, ALT; 10,933 U/ml in Wt mice vs 1,885 U/ml in Tg mice, P &amp;lt; 0.01). Histological analysis by Hematoxyline &amp; Eosin staining showed that the destruction of hepatic sinusoid with massive thrombosis was prominent in wt mice, whereas it was observed slightly in Tg mice.</p>
         </sec>
         <sec>
            <st>
               <p>Prevention of apoptosis in Tg mice</p>
            </st>
            <p>We found that TAA (100 &#8211;g/g) induces apoptosis in the liver of Wt mice. To determine whether Trx inhibits TAA-induced apoptosis in the liver, we checked the extent of apoptotic cells by TUNEL staining and DNA laddering assay. TUNEL-positive cells around the hepatic central vein of the livers were smaller in number in Tg mice than in Wt mice. DNA laddering was striking in TAA-treated livers of Wt mice, whereas it was hardly detected in TAA-treated livers of Tg mice.</p>
         </sec>
      </sec>
      <sec>
         <st>
            <p>Discussion</p>
         </st>
         <p>Trx has not only anti-oxidant effect but also anti-apoptotic effect. We have previously reported that Trx inhibits brain ischemic injury via anti-oxidative effect <abbrgrp><abbr bid="B4">4</abbr></abbrgrp>. We have also reported that Trx inhibited alcohol-induced hepatocyte cell death <abbrgrp><abbr bid="B5">5</abbr></abbrgrp>. The present study showed that Trx inhibited TAA-induced apoptosis of hepatocytes via the inhibition of cytochrome c release from mitochondria. We have previously reported that, in Jurkat T cells, a thioloxidant, diamide, induces cytochrome c release, resulting in caspase activation and apoptosis <abbrgrp><abbr bid="B6">6</abbr></abbrgrp>. This process is inhibited by Trx. In a clinical point of view, it has been reported that serum Trx level is upregulated in the serum of the patients with chronic hepatitis <abbrgrp><abbr bid="B7">7</abbr></abbrgrp>.</p>
         <p>In summary, we present evidence showing that TAA induces apoptosis of hepatocytes in the liver and that Trx inhibits TAA-induced apoptotic liver injury. This qualifies Trx as a promising gene therapy and a drug candidate for the treatment of acute hepatitis caused by virus infection and alcohol.</p>
      </sec>
   </bdy>
   <bm>
      <refgrp>
         <bibl id="B1">
            <title>
               <p>Thioredoxin</p>
            </title>
            <aug>
               <au>
                  <snm>Holmgren</snm>
                  <fnm>A</fnm>
               </au>
            </aug>
            <source>Annu Rev Biochem</source>
            <pubdate>1985</pubdate>
            <volume>54</volume>
            <fpage>237</fpage>
            <lpage>271</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1146/annurev.bi.54.070185.001321</pubid>
                  <pubid idtype="pmpid" link="fulltext">3896121</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B2">
            <title>
               <p>Redox regulation of cellular activation</p>
            </title>
            <aug>
               <au>
                  <snm>Nakamura</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Nakamura</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Jyodoi</snm>
                  <fnm/>
               </au>
            </aug>
            <source>Annu Rev Immunol</source>
            <pubdate>1997</pubdate>
            <volume>15</volume>
            <fpage>351</fpage>
            <lpage>369</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1146/annurev.immunol.15.1.351</pubid>
                  <pubid idtype="pmpid" link="fulltext">9143692</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B3">
            <title>
               <p>Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide</p>
            </title>
            <aug>
               <au>
                  <snm>Nakamura</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Matsuda</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Furuke</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Kitaoka</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Iwata</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Toda</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Inamoto</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Yamaoka</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Ozawa</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Yodoi</snm>
                  <fnm>J</fnm>
               </au>
            </aug>
            <source>Immunol Lett</source>
            <pubdate>1994</pubdate>
            <volume>42</volume>
            <fpage>75</fpage>
            <lpage>80</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/0165-2478(94)90038-8</pubid>
                  <pubid idtype="pmpid" link="fulltext">7829134</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B4">
            <title>
               <p>Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage</p>
            </title>
            <aug>
               <au>
                  <snm>Takagi</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Mitsui</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Nishiyama</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Nozaki</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Sono</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Gon</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Hashimoto</snm>
                  <fnm>N</fnm>
               </au>
               <au>
                  <snm>Yodoi</snm>
                  <fnm>J</fnm>
               </au>
            </aug>
            <source>Proc Natl Acad Sci</source>
            <pubdate>1999</pubdate>
            <volume>96</volume>
            <fpage>4131</fpage>
            <lpage>4136</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmcid">22432</pubid>
                  <pubid idtype="pmpid" link="fulltext">10097175</pubid>
                  <pubid idtype="doi">10.1073/pnas.96.7.4131</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B5">
            <title>
               <p>Geranylgeranylacetone enhances expression of thioredoxin and suppresses ethanol-induced cytotoxicity in cultured hepatocytes</p>
            </title>
            <aug>
               <au>
                  <snm>Hirota</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Nakamura</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Arai</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Ishii</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Bai</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Itoh</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Fukuda</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Yodoi</snm>
                  <fnm>J</fnm>
               </au>
            </aug>
            <source>Biochem Biophys Res Commun</source>
            <pubdate>2000</pubdate>
            <volume>275</volume>
            <fpage>825</fpage>
            <lpage>830</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1006/bbrc.2000.3392</pubid>
                  <pubid idtype="pmpid" link="fulltext">10973806</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B6">
            <title>
               <p>Redox regulation of caspase-3 protease activity: regulatory roles of thioredoxin and cytochrome c</p>
            </title>
            <aug>
               <au>
                  <snm>Ueda</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Nakamura</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Masutani</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Sasada</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Yonehara</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Takabayashi</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Yamaoka</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Yodoi</snm>
                  <fnm>J</fnm>
               </au>
            </aug>
            <source>J Immunol</source>
            <pubdate>1998</pubdate>
            <volume>161</volume>
            <fpage>6689</fpage>
            <lpage>6695</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">9862698</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B7">
            <title>
               <p>Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection</p>
            </title>
            <aug>
               <au>
                  <snm>Sumida</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Nakashima</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Yoh</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Nakajima</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Ishikawa</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Mitsuyoshi</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Sakamoto</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Okanoue</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Kashima</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Nakamura</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Yodoi</snm>
                  <fnm>J</fnm>
               </au>
            </aug>
            <source>J Hepatol</source>
            <pubdate>2000</pubdate>
            <volume>33</volume>
            <fpage>616</fpage>
            <lpage>622</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1034/j.1600-0641.2000.033004616.x</pubid>
                  <pubid idtype="pmpid" link="fulltext">11059866</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
      </refgrp>
   </bm>
</art>
